In addition, MYL9 was differentially expressed in many cancer types such as stomach adenocarcinoma, prostate adenocarcinoma, invasive carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, and squamous cell carcinoma. This evidence concerns the gene MYL9 and prostate adenocarcinoma.